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ABSTRACT 
 The inflammatory response represents a generalized response to infection or tissue damage 
and is designed to remove cellular debris, to localize invading organisms and arrest the spread 
of infection. NSAIDS are metabolized primarily in the liver. They vary in their half-lives and 
bioavailability. Given the multitude of available NSAIDs, the variability of their half-lives 
allows for different dosing regimens. The fluid in the inflamed area is known as inflammatory 
exudates, commonly called as pus. These exudates contain dead cells and debris in addition to 
body fluids. The inflammatory response is characterized by the following symptoms: 
Reddening of the localized area, swelling, pain and elevated temperature. Reddening results 
from capillary dialation that allows more blood to flow to the damaged tissue. Elevated 
temperature results from capillary dialation which permits increased blood flow through these 
vessels, with associated high metabolic activities of neutrophils and macrophages. The release 
of histamine from mast cells during antigen antibody reactions is well known, as is its 
involvement in the inflammatory response to skin injury. The present review focused on list 
and precautions of NSAID with its typed and classification, Analgesic activity study, 
histamine. 
 
Introduction 
 
The inflammatory response represents a generalized response 
to infection or tissue damage and is designed to remove 
cellular debris, to localize invading organisms and arrest the 
spread of infection. The inflammatory response is 
characterized by the following symptoms: Reddening of the 
localized area, swelling, pain and elevated temperature. 
Reddening results from capillary dialation that allows more 
blood to flow to the damaged tissue. Elevated temperature 
results from capillary dialation which permits increased blood 
flow through these vessels, with associated high metabolic 
activities of neutrophils and macrophages. The dialation of 
blood vessels is accompanied by increased capillary 
permeability causing swelling as fluid accumulates in the 
spaces surrounding tissue and cells. Pain in the case of 
inflammation is due to the lysis of blood cells that trigger the 
production of bradykinin and prostaglandins. The area of 
inflammation also becomes walled off as a result of the 
development of fibrinous clots. The deposition of fibrin 
isolates the inflamed area, cutting off normal circulation. The 
fluid in the inflamed area is known as inflammatory exudates, 
commonly called as pus. These exudates contain dead cells 
and debris in addition to body fluids. After the expulsion of 
the exudates, the inflammation may terminate and tissues may 
return to their normal state (Atlas, 1995).  Pain belongs to a 
basic sensory abnormality associated with inflammation. Pain 
develops when nerve fiber terminals of polynodal nociceptors 
become sensitized by mediators of inflammation. The pain 
producing inflammatory mediators are bradykinin, 
prostaglandins (PGE1 and PGE2) and leukotrienes,  
especially LTB4. Pain becomes evoked by the synergistic 
action of bradykinin and prostaglandins (Antoni, 1991). Based 
on visual observation, the ancients characterised inflammation 
by five cardinal signs, namely redness (rubor), swelling 
(tumour), heat (calor; only applicable to thebody'extremities), 
pain (dolor) and loss of function (functio laesa). The first four 
of thesesigns were named by Celsus in ancient Rome (30–38 
B.C.) and the last by Galen (A.D 130–200). Inflammation is a 
complicated and not fully understood communication between 
cellular and humoral elements. More recently, inflammation 
was described as "the succession of changes which occurs in a 
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living tissue when it is injured provided that the injury is not 
of such a degree as to at once destroy its structure and 
vitality". Inflammation is a normal, protective response to 
tissue injury caused by physical trauma, noxious chemicals or 
microbiological agents. The inflammatory response is 
characterized by the following symptoms: Reddening of the 
localized area, swelling, pain and elevated temperature. 
Reddening results from capillary dialation that allows more 
blood to flow to the damaged tissue. Elevated temperature 
results from capillary dialation which permits increased blood 
flow through these vessels, with associated high metabolic 
activities of neutrophils and macrophages. The dialation of 
blood vessels is accompanied by increased capillary 
permeability causing swelling as fluid accumulates in the 
spaces surrounding tissue and cells. Pain in the case of 
inflammation is due to the lysis of blood cells that trigger the 
production of bradykinin and prostaglandins. The area of 
inflammation also becomes walled off as a result of the 
development of fibrinous clots. The deposition of fibrin 
isolates the inflamed area, cutting off normal circulation. The 
fluid in the inflamed area is known as inflammatory exudates, 
commonly called as pus. These exudates contain dead cells 
and debris in addition to body fluids. After the expulsion of 
the exudates, the inflammation may terminate and tissues may 
return to their normal state (Atlas, 1995). Pain develops when 
nerve fiber terminals of polynodal nociceptors become 
sensitized by mediators of inflammation. The pain producing 
inflammatory mediators are bradykinin, prostaglandins (PGE1 
and PGE2) and leukotrienes,especially LTB[1-9]. Pain 
becomes evoked by the synergistic action of bradykinin and 
prostaglandins. 
 
Causes of inflammation 
 
The numerous causes of inflammation may be classified as 
follows: 
• Microbes-e.g. bacteria, viruses, protozoa, fungi, 
• Physical agents- e.g. heat, cold, mechanical injury, 
ultraviolet and ionising radiation. 
• Chemical agent- 
-organic: e.g: microbial toxins, organic posion 
-inorganic: e.g: acids, alkalis[Ross n Wilson 
P.N.371] 
 
Types of inflammation 
 
Figure 1: Types of inflammation 
 
Acute Inflammation 
 
These inflammation having short duration process E.g: days to 
a few weeks, and may range from mild to a very severe. The 
cardial signs of inflammation are, redness, heat, pain, 
swelling, loss of function. The acute inflammatory response is  
 
described as a collection of overlapping events, increased 
blood flow, accumulation of tissue fluid, migration of 
leucocytes, increased core temperature, pain and suppuration. 
some of the most important substances released in 
inflammation as shown in table: 
Table 1: Acute Inflammation 
 
Substance 
 
Made by 
 
Trigger for release 
 
Main pro inflammatory action 
Histamine mast cells (in most 
tissue),basophils(blood),store
d in cytoplasmic granules 
Binding of antibody to 
mast cell and basophils 
Vasodilation,itching,increase vascular 
permeability,degranulation,smoothmuscle 
contraction(e.g.bronchocostriction) 
Serotonin 
(5-HT) 
Platelet mast cell and 
basophils(stored in 
granules)also in CNS(acts as 
When platelets are 
activated,and when 
mast cells/basophils 
Vasoconstrictions,increases permeability 
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Figure 2: Acute Inflammation 
 
Chronic Inflammation 
 
Figure 3: Chronic Inflammation 
neurotransmitter) degranulate 
Prostaglandi
ns 
(PGs) 
Nearly all cells not stored but 
made feom cell membrane as 
required 
Many differnt stmuli 
e.g drugs,toxins,other 
inflammatory 
mediators,hormones 
Diverse,sometimes 
opposing,e.g.fever,pain,vasodilation or 
vasoconstriction,increases vascular 
permeability 
Heparin Liver,mast 
cell,basophilis,(stored in 
cytoplasmic granules) 
Released when cells 
degranulte 
Anticoagulant(prevents blood clotting),which 
maintains blood supply(nutients O2)to injuried 
tissue  and washes away microbes and wastes 
Bradykinin Tissue and blood When blood clots,in 
trauma and 
inflammation 
Pain 
vasodilation 
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This process having a longer duration of action ,considerably 
more tissue is likely to be destroyed.The process involved is 
same as the acute inflammation.The inflammatroy cells are 
mainly lymphocytes instead of neutrophilis and fibroblasts are 
activated,leading to the laying down of collagen,and fibrosis.If 
the body defences are unable to clear the infection,they may 
try to wall it off instead,forming nodules called as 
granulomas,within which are collection of defensive 
cells.Tuberculosis is an example of an infection that frequently 
becomes chronic,leading to grnuloma formation.The causative 
agent is mycobacterium tuberculosis,is resistant to body 
defence and so pockets of organism are sealed up in 
granulomas within the lungs.  
 
Classification of NSAIDs 
 
A. Non selective COX inhibitors (traditional NSAIDs) 
1. Salicylates:Aspirin 
2. Propionic acid derivatives:Ibuprofen 
3. Anthranilic acid derivatives:Mephenamic acid 
4. Aryl-acetic acid 
derivatives:Diclofenac,Acelofenac 
5. Oxicam derivatives:Piroxicam,Tenoxicam 
6. Pyrrolo-pyrrole derivatives:Ketorolac 
7. Indole derivatives:Indomethacian 
8. Pyrazolone derivatives:Phenyl 
butazone,Oxyphenbutazone 
B. Preferential COX-2 inhibitors 
1. Nimesulid, Meloxicam, Nabumetone 
C. Selective Cox-2 inhibitors 
1. Celecoxib, Etoricoxib, Parecoxib 
D. Analgesic Antipyretic with poor inflammatory action 
2. Paraaminophenol derivatives:paracetamol 
3. Pyrazolone derivatives:Metamizol,propiphenazone 
4. Benzoxazocine derivatives:Nefopam [k d tripathi 
P.N.184] 
Marketed preparations and dose[2-5] 
A. Nonselective COX-2 inhibitors 
1. Salicylates 
• Aspirin- 
• Ecospirin 75,150,325,mg tablets 
• Disprin 350 mg tablets 
• Aspirin 350 mg tablets 
• An injectable preparation has been made available 
recently: 
• Biospirin:Lysine acetylsalicylate 900 mg+ glycine 
100mg/vial for dissolving 5 mlwater and i.v. injection 
[k d tripathi P.N.191] 
2. Propionic acid derivatives 
• Ibuprofen: 
Ibugesic plus tablets 
Combination of aspirin(650mg) and codeine(60mg) 
in reliving dental surgery pain 
• Naproxen: 
In acute gout dose 750 mg stat followed by 250 mg 8 
hourly till attack subsides 
• Ketoprofen: 
Ketorol DT tablet 
• Flurbiprofen: 
Ocuflur,flur,flurbin,0.03% eyedrops,1 drop of 6 
hourly [k d tripathi P.N.193] 
3. Anthranilic acid derivatives 
• Mephanamic acid: 
Dose:250-500 mg, Medol 250-500 mg capsule, 
Meftal 250,500 mg tablet,100mg/5 ml 
suspension,Ponstan 125,250,500 mg tablet,50 mg/ml 
syrup [k d tripathi P.N.193,194] 
4. Aryl acetic acid derivatives 
• Diclofenac sodium: 
Dose:50 mg TDS,then BD oral,75 mg deep i.m. 
Voveran,Diclonac, monovac 50 mg enteric coated 
tablet,100 mg S.R.tablet,25mg/ml in 3 amp.for 
i.m.inj. Diclomax 25,50mg tablet, 
• Diclofenac potassium: 
Voltaflam 25,50 mg tablets, Ultra-k 50 mg tablets, 
Voveran 1% topical gel, Diclonac 0.1% eye 
drops.[k.d tripathi 193,194] 
5. Oxicam Derivatives 
• Piroxicam: 
Dose:20 mg BD for two days followed by 20 mg 
OD;Dolonex,pirox 10,20 mg capsule,20 mg 
dispersible tablets,20 mg/ml injection in 1 and 2 ml 
amps,Piricam 10,20 mg Capsule 
• Tenoxicam: 
Tobitil 20 mg tablets, dose 20 mg OD 
[k.d.tripathi.194] 
6. Pyrrolo-pyrrole derivatives 
• Ketorolac: 
Ketorol, zorovon, ketanov, torolac 10 mg tablets,30 
mg in 1 ml amp. 
Ketlur,acular 0.5% eye drops ,1-2 drops 2-4 times a 
day for noninfective ocular inflammatory 
conditions.[k.d.tripathi.194,195] 
7. Indole derivatives 
• Indomethacin: 
Dose:25-50 mg BD-QID.those not tolerating the drug 
orally may be given nightly suppository. 
Idicin, Indocap 25 mg capsule,75 mg SR capsule, 
Indoflam 25,75 mg capsules,1% eye drops. Recticin 
50 mg suppository [k.d.tripathi 195] 
8. Pyrazolones derivatives 
• Phenyalbutazone 
Esgipyrin tablets 
B. Preferential COX-2 inhibitors 
• Nimesulide 
Dose:100 mg BD; nimulid,nimgesic,nimodol 100 mg 
tablet,50mg/5ml suspension 
• Meloxicam 
Dose:7.5-15 mg OD;melflam,mel OD,muvik,mcam 
7.5 mg,15 mg tablets 
• Nabumetone 
Nabuflam 500 mg tablets;1 tablet OD 
C. Selective COX-2 inhibitors 
• Celecoxib 
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Celact,revibra,colcibra 100,200 mg capsule 
• Etoricoxib 
Dose:60-120 mg OD;Etody,torocoxia,etoxib,nucoxia 
60,90,120 mg tablets 
• Parecoxib 
Dose:40 mg oral/i.m /i.v.repeated after 6-12 
hours.Revaldo,valto-p 40 mg/vial inj.,paroxib 40 mg 
tablet 
D. Analgesic Anti pyretics with poor anti inflammatory 
action 
• Paraaminophenol derivatives 
a.Paracetamol 
Metacin,paracin 500 mg tablets,125mg/5 ml syrup,  
Crocin pain relief 650 mg + caffeine 50 mg tablets 
• Pyrazolone Derivatives 
a.Propiphenazone 
Pyrlfil tablet 
• Benzoxazocine derivatives 
Nefopam 
Dose: 30-60 mg TDS oral,20 mg i.m. 6 hourly. 
Nefomax 30 mg tablets,20 mg in 1 ml ampule. 
 
Mechanism of action of NSAIDs 
 
Anti inflammatory 
The most important mechanism of anti inflammatory action of 
NSAIDs is considered to be inhibition of PG synthesis at the 
site of injury.The antiinflammatory potency of different 
compounds roughly corresponds with their potency to inhibit 
COX. However, nimesulide is a potent anti-inflammatroy but 
relatively weak COX inhibitor. PGs are only one of the 
mediators of inflammation; inhibition of COX does not 
depress the production of other mediators like LTs, PAF, 
cytokines etc. Inflammation is the result of concerted 
participation of large number of vasoactive, chemotactic and 
proliferative factors at different stage, and there are many 
targets for inflammatory action[8-11]. 
Features of non selective COX inhibitors and selective COX-2 
inhibitors:  
Table 2: COX inhibitors and selective COX-2 inhibitors 
 
Action COX-1/COX-2inhibitors COX-2 inhibitors 
1.Analgesic + + 
2.Antipyretic + + 
3.Antiinflammatory + + 
4.Antiplatelet aggregatory + - 
5.Gastric mucosal damage + - 
6.Renal salt/water retantion + + 
7.Delay/prolongation of labour + + 
8.Ductus arteeriosus closure + ? 
9.Aspirin sensitive asthma 
precipitation 
+ - 
 
Antipyretic effect 
 
NSAIDs exert their antipyretic effect by inhibition of 
prostaglandin E2 (PGE2) synthesis, which is responsible for 
triggering the hypothalamus toincrease body temperature 
during inflammation. 
 
Analgesic effect 
 
Although they are classified as mild analgesics, NSAIDs have 
a more significant effect on pain resulting from the increased 
peripheral sensitization that occurs during inflammation and 
leads no receptors to respond to stimuli that are normally 
painless. In particular, it is believed that inflammation leads to 
a lowering of the response threshold of poly modal no 
receptors. 
 
Pharmacokinetic 
 
NSAIDS are metabolized primarily in the liver. They vary in 
their half-lives and bioavailability. Given the multitude of 
available NSAIDs, the variability of their half-lives allows for 
different dosing regimens. Although decreased frequency of 
dosing improves compliance as a general rule, consideration 
must be given to the increase in renal dysfunction associated 
with longer-acting NSAIDs. It has also been speculated that 
use of daily dosed medications, by improving compliance, 
may increase the risk for GI bleeding. Variability in 
susceptibility to adverse effects of various NSAIDs does not 
seem to be due to difference in pharmacokinetics. Hepatic 
function, renal function, and age must be considered before 
prescribing and dosing. 
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Catabolic pathway of AA 
 
Figure 4: Catabolic pathway of AA 
 
Mediators  
 
 
Figure 5: Mediators 
 
 
Figure 6: Mediators 
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Figure 7: Mediators 
Histamine 
 
The release of histamine from mast cells during antigen 
antibody reactions is well known, as is its involvement in the 
inflammatory response to skin injury. Also, increased numbers 
of mast cells are present in the rheumatoid synovium and in 
the asthmatic lung, correlated with raised levels of histamine. 
The advent of non sedating H1 antihistamines has allowed 
them to be tested in much higher doses than ever before, and 
some evidence suggests that histamine may play a role in 
allergic asthma[11-15]. 
 
Bradykinin 
 
Small amounts of bradykinin cause pain, vasodilatation, and 
edema, all contributing to inflammation. Bradykinin-like 
immunoreactivity has been detected in rat pleural 
inflammatory exudates. Kinins are also present in nasal 
secretions after immunological challenge, and a kininogenase 
is released from human lung mast cells. Inhaled bradykinin 
causes bronchoconstriction in normal and asthmatic 
individuals, but not through release of PGs. 
 
Thromboxane A2 and prostacyclin 
 
The anti platelet effects of aspirin could not be explained by 
inhibition of the synthesis of PGE2 or PGF2a because these 
PGs do not affect platelet aggregation to any great extent. 
Prostacyclin, as it was later termed, relaxes blood vessels and 
inhibits aggregation of platelets. Its synthesis in endothelial 
cells of blood vessel walls is of special importance. 
 
Interleukin-l 
 
IL-i is a polypeptide produced by activated macrophages that 
mimics the symptoms of chronic inflammation. It has had  
 
other names, including endogenous pyrogen. IL-i-like activity 
(equivalent to 1.69 U/mi) has been detected in synovial fluids 
from patients with rheumatoid arthritis. Its actions include 
activation of lymphocytes and production of fever, the latter 
being mediated by release of PGE2. 
 
The prostaglandins 
 
Apart from non nucleated erythrocytes, all cells are capable of 
synthesizing PGs, which are released in response to many 
kinds of trauma or any disturbance of the cell membrane. In 
other words, the pathological release of PGs that contributes to 
inflammation, fever, and pain is inhibited by aspirin and other 
NSAIDs. The aspirin like drugs also share, to a greater or 
lesser extent, certain side effects, such as a propensity to 
irritate the stomach, nephrotoxicity in high concentrations, and 
interference with the birth process. It was suggested that these 
side effects resulted from the inhibition of the physiological 
release of a protective PG. 
 
Platelet-activating factor (PAF) 
 
The phospholipid PAF-ac ether is released by the action of 
phosphor lipase A2 from most pro inflammatory cells, as well 
as by vascular endothelial cells and platelets .It induces 
inflammatory reactions in various animal species and in 
human skin. PAF also mimics themain clinical features of 
asthma and is particularly effective in producing hyper 
reactivity and accumulation of eosinophils in lung tissue. 
Asthmatic patients have high levels of circulating PAF and 
their eosinophils make more PAF than those of normal 
controls. The anti asthmatic glucocorticoids, by suppressing 
phospholipase A2, will thus reduce the formation of PAF. 
Furthermore, PAF antagonists, such as the ginkgolides, are 
currently being investigated for the treatment of asthma. 
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Figure 8: Histamine 
 
NSAID (List of non steroidal anti-inflammatories) 
 
• Aspirin (Anacin, Ascriptin, Bayer, Bufferin, Ecotrin, 
Excedrin) 
• Choline and magnesium salicylates (CMT, Tricosal, 
Trilisate) 
• Choline salicylate (Arthropan) 
• Celecoxib (Celebrex) 
• Diclofenac potassium (Cataflam) 
• Diclofenac sodium (Voltaren, Voltaren XR) 
• Diclofenac sodium with misoprostol (Arthrotec) 
• Diflunisal (Dolobid) 
• Etodolac (Lodine, Lodine XL) 
• Fenoprofen calcium (Nalfon) 
• Flurbiprofen (Ansaid) 
• Ibuprofen (Advil, Motrin, Motrin IB, Nuprin) 
• Indomethacin (Indocin, Indocin SR) 
• Ketoprofen (Actron, Orudis, Orudis KT, Oruvail) 
• Magnesium salicylate (Arthritab, Bayer Select, Doan's 
Pills, Magan, Mobidin, Mobogesic) 
• Meclofenamate sodium (Meclomen) 
• Mefenamic acid (Ponstel) 
• Meloxicam (Mobic) 
• Nabumetone (Relafen) 
• Naproxen (Naprosyn, Naprelan*) 
• Naproxen sodium (Aleve, Anaprox) 
• Oxaprozin (Daypro) 
• Piroxicam (Feldene) 
• Rofecoxib (Vioxx) 
• Salsalate (Amigesic, Anaflex 750, Disalcid, Marthritic, 
Mono-Gesic, Salflex, Salsitab) 
• Sodium salicylate (various generics) 
• Sulindac (Clinoril) 
• Tolmetin sodium (Tolectin) 
• Valdecoxib (Bextra) 
Note: Some products, such as Excedrin, are combination drugs 
(Excedrin is acetaminophen, aspirin, and caffeine). Note that 
acetaminophen (Paracetamol; Tylenol) is not on this list. 
Acetaminophen belongs to a class of drugs called analgesics 
(pain relievers) and antipyretics (fever reducers). The exact 
mechanism of action of acetaminophen is not known. 
Acetaminophen relieves pain by elevating the pain threshold, 
that is, by requiring a greater amount of pain to develop before 
it is felt by a person. It reduces fever through its action on the 
heat-regulating center of the brain. Specifically, it tells the 
center to lower the body's temperature when the temperature is 
elevated. Acetaminophen relieves pain in mild arthritis but has 
no effect on the underlying inflammation, redness and 
swelling of the joint Paracetamol, unlike other common 
analgesics such as aspirin and ibuprofen, has no anti-
inflammatory properties, and so it is not a member of the class 
of drugs known as non-steroidal anti-inflammatory drugs or 
NSAIDs. 
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Latest anti-inflammatory drugs 
Table 3: Latest anti-inflammatory drugs 
Recent drug Dosage form Drug content 
Acecloflam Tablet Acelofenac 100 mg 
Paracetamol 325 mg 
Serratiopeptidase 10mg 
Etocoxiv Tablet Etoricoxib30, 60,120 mg 
Fleura D Soft gel.capsule Diclofinac 50 mg 
Metaxalone 400mg 
Muvera Tablet Meloxicam 15,30mg 
 
NSAIDs should never be combined 
 
Preferentialy inhibitors of cyclo-oxygenase-2[cox 2] such as 
meloxicam and the specific cox 2 inhibitor celecoxib are 
approved for pain relief in osteoarthritis(OA).Although their 
analgesic efficacy has been established their ability to 
significantly reduce gastrointestinal(GI) side effects  has not 
been convincingly proven. They should also be used with 
caution in patients with renal or heart failure. Recent 
evidences on the relative safety of oral NSAIDs have indicated 
differences in the risk of serious upper gastro intenstinal side 
effects as per following scale[5-21]: 
 
Lowest Risk 
Ibuprofen 
 
Intermediate Risk 
Diclofenac, Indomethacin, Ketoprofen, Naproxen, 
Nimesulide, Piroxicam, Celecoxib. Higher in the case of 
nimesulid  And possibly higher in the case of piroxicam 
 
Highest Risk 
Azapropazone It is suggested that NSAIDs should generally 
be preferred to start at lowest recommended dose not to use 
more than one oral NSAIDs at a time and to remember that all 
NSAIDs are contraindicated in patients with peptic ulceration. 
 
Opioids 
Weak opioids such as codeine or dihydrocodiene,used alone ir 
in combination with paracetamol may be effective option if 
paracetamol does not relive pain or NSAIDs are unsuitable. 
constipation is common, especially  in the elderly but it may 
be minimised by encouraging a high fibre diet and plenty of 
fluids prescribing prophylactic laxatives. 
Other Drugs: 
Topical analgesic such as NSAIDs, capsaicin, or rubefacients 
may also provides some degree of pain relief in OA. 
[P.N.147,148. MIMS volume 34 number 4.April 2004]  
Analgesic activity study[8-19] 
 
Hot-plate method (Thermal stimulus)   
 
The mice selected were weighted (25-30g) and groups into 
eight of six in each and the normal basal reaction time were 
taken by repeating for 5 times. Group-3 to Group-5 received  
chloroform extract and Group-6 to Group-8 received methanol 
extracts respectively at a dose of 50mg/kg, 100 mg/kg and 
200mg/kg body weight (p.o.). Group- 2 received Morphine 
sulphate 5mg/kg body weight (s.c.) and served as standard. 
Group- 1 administrated 1% DMSO in the dose of 10ml/kg 
body weight (p.o.) served as control. All animals were 
lowered onto the surface of a hot plate (50±1.00C) enclosed 
with cylindrical glass and the time for the animal to jump or 
lick the fore limb was noted as the reaction time (RT). Cut off 
time in the absence of a response was 15 sec to prevent the 
animals from being burnt. The observations were made before 
and after administration of respective drugs at 30 min, 60 min, 
120 min, and at the end of 180 min. 
 
Tail immersion Test (Thermal stimulus) 
 
The Swiss albino mice were selected by immersing the tail in 
hot water at temperature 550 C ±50C and the basal reaction 
time was noted. The mice which showed a positive response 
within a span of 5 seconds for withdrawal of the tail clearly 
out of water were selected for further studies. The mice 
selected were weighted (25-30g) and groups into eight of six 
in each and the normal basal reaction time were taken by 
repeating for 5 times. Group 3 to Group 5 received chloroform 
extract and Group 6 to Group 8 received methanol extract 
respectively at a dose of 50mg/kg, 100 mg/kg and 200mg/kg 
body weight. Group 2 received Morphine sulphate 5mg/kg 
body weight (s.c.) and served as a positive control. Group 1 
served as solvent control (1% DMSO) and received the dose 
of 10ml/kg body weight. The observations were made before 
and after administration of respective drugs at 30 min, 60 min, 
120 min, and at the end of 180 min. 
 
Writhing Test (Chemical stimulus)  
 
Aspirin like non-narcotic analgesic activity of the test extracts 
was investigated by the ability to protect a painful writhing 
syndrome in mice. The syndrome is characterized by 
abdominal torsion, drawing up of hind limbs to the abdominal 
wall, marked contraction of the abdominal area and periodical 
arching of the back to rub the abdominal wall on the glazed 
surface on which the mouse is kept. Writhing was consistently 
produced in mouse by an intra peritoneal injection of 0.6% 
aqueous acetic acid. Overnight fasted, healthy adult male 
albino Swiss mice weighing between 18 to 25gm in groups of 
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six each were taken for present investigation. DMSO 1% 
solution of the test extracts were administered orally in a dose 
of 50mg/kg, 100mg/kg and 200mg/kg body weight 
respectively to the test groups animal.  The control group of 
animals were given only DMSO 1% solution in the dose of 
10ml/kg body weight. One group of animal was administered 
with Diclofenac sodium as standard, orally in a dose of 
5mg/kg (b.w). After a gap of 30 minutes of the administration 
of the test extracts, all the groups of mice were given the 
writhing agent, 0.6% aqueous acetic acid, in a dose of 
1ml/100gm (b.w) intra peritoneally. Five minutes after 
administration of acetic acid the number of writhing produced 
in these animals were counted for next 10 minutes and the 
number of writhing produce in the treated groups were 
compared with those in the control group and the percentage 
protection was calculated as show below, 
Percentage protection = [(No.of writhes in control - No. of 
writhes in test)/ No. of writhes in control] x 100 
 
Conclusion 
 
These suggestions are very helpful for most people with 
inflammatory conditions such as sprains, strains, bursitis, 
tendonitis, arthritis, etc. and can be used in conjunction with 
supplementation. Most people find that eating this way also 
often lowers blood lipids, smoothes out blood sugar variations, 
helps with weight management, reduces digestive problems, 
increases energy, and more. 
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